EUVIMEDEUVIMED entdecken
Crossref

Percutaneous Femoral Arterial Closure Following Decannulation of Venoarterial Extracorporeal Membrane Oxygenation Using the MANTA Vascular Closure Device

Riley J Batchelor, Arne Diehl, Thodur Vasudevan, Shane Nanayakkara, Nay Htun, Vincent Pellegrino, David McGiffin, Silvana Marasco, Carol Hodgson, David Kaye, Dion Stub, Antony Walton

Heart, Lung and Circulation · 2025

DOI: 10.1016/j.hlc.2025.06.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2025. Verfasst von Riley J Batchelor und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Alfred Health, Melbourne, Vic, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Vi…. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Femoral Artery, Vascular Closure Devices, Device Removal. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Health and Medical Research Council, National Heart Foundation of Australia, Teleflex.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a life-saving therapy for patients with severe cardiac failure. If patients can be weaned, withdrawal and closure of the large-bore arterial access are required, which historically have been achieved through surgical closure. The MANTA vascular closure device (VCD) is a percutaneous, collagen-based plug device used following large-bore arterial access. We sought to evaluate the efficacy and safety of the MANTA VCD for percutaneous arterial closure following VA-ECMO decannulation. METHOD: A non-randomised, open-label pilot study of patients who underwent decannulation from VA-ECMO with percutaneous closure using the MANTA VCD. RESULTS: Eight patients presenting with cardiogenic shock (mean age 46.5±11.4 years, 37.5% female) underwent percutaneous closure following VA-ECMO decannulation using the 18 Fr MANTA VCD. The mean duration of VA-ECMO support prior to decannulation was 4.8±2.6 days, with arterial cannula sizes ranging from 15 to 19 Fr. There were two major adverse events: one patient had acute limb ischaemia due to superficial femoral artery occlusion, which was detected during percutaneous closure and treated surgically; another patient developed a femoral pseudoaneurysm and infected hematoma that subsequently required surgical repair 17 days after percutaneous closure. CONCLUSIONS: In a centre with immediate access to vascular surgical backup, and in highly selected patients, percutaneous closure following VA-ECMO decannulation using the MANTA VCD is feasible; however, major vascular complications raise concerns regarding safety prior to its adoption as an alternative to up-front surgical closure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationFemoral ArteryVascular Closure DevicesDevice RemovalShock, CardiogenicHumansFemaleMiddle AgedMalePilot ProjectsAdult

Stichwörter der Autor:innen

Cardiogenic shockECMOIntensive careInterventional cardiologyPercutaneous closure

Autor:innen und Institutionen

  • Department of Cardiology, Alfred Health, Melbourne, Vic, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.
  • Intensive Care Unit, Alfred Health, Melbourne, Vic, Australia.
  • Department of Vascular Surgery, Alfred Health, Melbourne, Vic, Australia.
  • Department of Cardiology, Alfred Health, Melbourne, Vic, Australia.
  • Department of Cardiothoracic Surgery, Alfred Health, Melbourne, Vic, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia; Intensive Care Unit, Alfred Health, Melbourne, Vic, Australia.

Förderung

  • National Health and Medical Research Council
  • National Heart Foundation of Australia
  • Teleflex

Zitieren

APA

Batchelor, R. J., Diehl, A., Vasudevan, T., Nanayakkara, S., Htun, N., Pellegrino, V., McGiffin, D., Marasco, S., Hodgson, C., Kaye, D., Stub, D., & Walton, A. (2025). Percutaneous Femoral Arterial Closure Following Decannulation of Venoarterial Extracorporeal Membrane Oxygenation Using the MANTA Vascular Closure Device. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2025.06.006

Vancouver

Batchelor RJ, Diehl A, Vasudevan T, Nanayakkara S, Htun N, Pellegrino V, et al. Percutaneous Femoral Arterial Closure Following Decannulation of Venoarterial Extracorporeal Membrane Oxygenation Using the MANTA Vascular Closure Device. Heart, Lung and Circulation. 2025. doi:10.1016/j.hlc.2025.06.006

BibTeX
@article{Batchelor2025,
  author = {Batchelor, Riley J and Diehl, Arne and Vasudevan, Thodur and Nanayakkara, Shane and Htun, Nay and Pellegrino, Vincent and McGiffin, David and Marasco, Silvana and Hodgson, Carol and Kaye, David and Stub, Dion and Walton, Antony},
  title = {Percutaneous Femoral Arterial Closure Following Decannulation of Venoarterial Extracorporeal Membrane Oxygenation Using the MANTA Vascular Closure Device},
  journal = {Heart, Lung and Circulation},
  year = {2025},
  doi = {10.1016/j.hlc.2025.06.006}
}
Kostenlos starten →